Immunology of Mycobacterium tuberculosis Infections

JK Sia, J Rengarajan - Microbiology spectrum, 2019 - Am Soc Microbiol
Tuberculosis (TB) is a serious global public health challenge that results in significant
morbidity and mortality worldwide. TB is caused by infection with the bacilli Mycobacterium …

[HTML][HTML] Tuberculosis and lung damage: from epidemiology to pathophysiology

S Ravimohan, H Kornfeld, D Weissman… - European respiratory …, 2018 - Eur Respiratory Soc
A past history of pulmonary tuberculosis (TB) is a risk factor for long-term respiratory
impairment. Post-TB lung dysfunction often goes unrecognised, despite its relatively high …

Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted

KJ Greenlee, Z Werb… - Physiological reviews, 2007 - journals.physiology.org
The matrix metalloproteinases (MMPs), a family of 25 secreted and cell surface-bound
neutral proteinases, process a large array of extracellular and cell surface proteins under …

Tuberculosis, pulmonary cavitation, and matrix metalloproteinases

CWM Ong, PT Elkington, JS Friedland - American journal of …, 2014 - atsjournals.org
Tuberculosis (TB), a chronic infectious disease of global importance, is facing the
emergence of drug-resistant strains with few new drugs to treat the infection. Pulmonary …

Hypoxia and tissue destruction in pulmonary TB

M Belton, S Brilha, R Manavaki, F Mauri, K Nijran… - Thorax, 2016 - thorax.bmj.com
Background It is unknown whether lesions in human TB are hypoxic or whether this
influences disease pathology. Human TB is characterised by extensive lung destruction …

Matrix metalloproteinases in destructive pulmonary pathology

PTG Elkington, JS Friedland - Thorax, 2006 - thorax.bmj.com
Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that have a number of
important physiological roles including remodelling of the extracellular matrix, facilitating cell …

[HTML][HTML] MMP-1 drives immunopathology in human tuberculosis and transgenic mice

P Elkington, T Shiomi, R Breen… - The Journal of …, 2011 - Am Soc Clin Investig
Most individuals infected with Mycobacterium tuberculosis develop a latent infection, which
does not progress to active tuberculosis (TB). This occurs, in part, because infected …

Host-directed therapies: modulating inflammation to treat tuberculosis

S Krug, S Parveen, WR Bishai - Frontiers in immunology, 2021 - frontiersin.org
Following infection with Mycobacterium tuberculosis, the causative agent of tuberculosis
(TB), most human hosts are able to contain the infection and avoid progression to active TB …

Host-directed therapeutics for tuberculosis: can we harness the host?

TR Hawn, AI Matheson, SN Maley… - … and Molecular Biology …, 2013 - Am Soc Microbiol
Treatment of tuberculosis (TB) remains challenging, with lengthy treatment durations and
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …

Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis

A Dorhoi, SHE Kaufmann - Seminars in immunopathology, 2016 - Springer
Heightened morbidity and mortality in pulmonary tuberculosis (TB) are consequences of
complex disease processes triggered by the causative agent, Mycobacterium tuberculosis …